333 studies found for:    immunoglobuling OR Inmunoglobulina [TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Recruiting Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy
Conditions: Pancreatic Neoplasms;   Inflammation
Intervention: Other: gemcitabine-based chemotherapy
2 Active, not recruiting IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
Condition: Asthma
Intervention: Drug: Immune Globulin
3 Completed PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency
Condition: IgG Deficiency
Intervention: Biological: Prevenar13
4 Completed A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
Conditions: Immune Thrombocytopenic Purpura ( ITP );   HIV Infections
Intervention: Drug: CD4-IgG
5 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: CD4-IgG
6 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: CD4-IgG
7 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Interventions: Drug: CD4-IgG;   Drug: Zidovudine
8 Terminated GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Conditions: Severe Sepsis;   Septic Shock
Intervention: Drug: Immunoglobulin G
9 Completed Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
Condition: Primary Immune Deficiency
Intervention: Drug: Immunoglobulin G (Ig NextGen 16%)
10 Terminated IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
Condition: Clostridium Difficile-associated Diarrhea (CDAD)
Intervention: Drug: intravenous immunoglobulin G (IVIG)
11 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Polygam® S/D;   Drug: Placebo
12 Recruiting Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Biological: HYQVIA;   Biological: 0.25% albumin placebo solution with rHuPH20;   Biological: IGIV
13 Not yet recruiting Effect of Privigen Against Graft Loss
Condition: Kidney Transplantation
Intervention: Drug: Privigen (Human normal immunoglobulin G (IgG > 98 % purity))
14 Completed
Has Results
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Conditions: Common Variable Immunodeficiency;   Agammaglobulinemia
Intervention: Drug: Vivaglobin
15 Recruiting Belatacept in Kidney Transplantation of Moderately Sensitized Patients
Conditions: End Stage Renal Disease;   Antibody Mediated Rejection
Interventions: Drug: Belatacept;   Drug: Tacrolimus withdrawal;   Procedure: Plasmapheresis/Intravenous Immunoglobulin G;   Drug: Thymoglobulin (ATG);   Drug: Myfortic;   Drug: Steroids
16 Completed
Has Results
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
Conditions: 13-valent Pneumococcal Vaccine;   Premature Birth;   Immunization;   Safety
Intervention: Biological: 13-valent pneumococcal conjugate vaccine
17 Completed Phase II Study to Evaluate Safety and Efficacy of Intravenous Immunoglobulin G Degrading Enzyme of Streptococcus Pyogenes (IdeS) in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Biological: IdeS
18 Completed
Has Results
A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.
Condition: Healthy Subjects
Interventions: Biological: 7-pneumococcal conjugate vaccine (7vPnC);   Biological: diphtheria, tetanus, and acellular pertussis vaccine (DTaP);   Biological: DTaP
19 Completed
Has Results
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
Condition: Healthy Subjects
Interventions: Biological: 13-valent pneumococcal conjugate vaccine (13vPnC);   Biological: diphtheria, tetanus, and acellular pertussis vaccine (DTaP);   Biological: 7-valent pneumococcal conjugate vaccine (7vPnC);   Biological: DTaP
20 Completed Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
Condition: Immunologic Deficiency Syndrome
Intervention: Drug: Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years